Australian State & Territory variations from Part 4 of the Poisons Standard

Scheduling medicines & poisons

28 November 2017

Part 4 of The Poisons Standard is a record of decisions regarding the classification of medicines and chemicals into Schedules. States and territories can refer to the Poisons Standard as published or enact state or territory variations to the Poisons Standard. Variances in each state and territory from Part 4 of the Poisons Standard are summarised below. This information will be updated annually.

Australian Capital Territory

Departure from Part 4 of the Poisons Standard Justification Effect on suppliers or consumers
Exemption for piper methysticum (kava) if prepared, possessed and consumed in accordance with the customs of the Pacific Islands in connection with an event declared by the Minister as per section 864 Medicines, Poisons and Therapeutic Goods Regulation 2008. Recognition of the cultural importance of kava to people of Pacific Island origin. Further details may be accessed at ACT HealthMedicines, Poisons and Therapeutic Goods Regulation 2008 or Pharmaceutical Services.

New South Wales

Departure from Part 4 of the Poisons Standard Justification Effect on suppliers or consumers
No variations

Northern Territory

Departure from Part 4 of the Poisons Standard Justification Effect on suppliers or consumers
No variations

Queensland

Departure from Part 4 of the Poisons Standard Justification Effect on suppliers or consumers
No variations

South Australia

Departure from Part 4 of the Poisons Standard Justification Effect on suppliers or consumers
No variations

Tasmania

Departure from Part 4 of the Poisons Standard Justification Effect on suppliers or consumers
No variations

Victoria

Departure from Part 4 of the Poisons Standard Justification Effect on suppliers or consumers
No variations

Western Australia

See Medicines and Poisons Act 2014

Departure from Part 4 of the Poisons Standard Justification Effect on suppliers or consumers
Addition to Schedule 4 of SCAEVOLA SPINESCENS. To limit use of an extract of the plant for the treatment of cancer. Must be supplied as a prescription medicine.